Position
CERTUITY, LLC in 10x Genomics, Inc.
Back to the book · All holders of TXG
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $99.4K$16.31 → $21.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 20.2K | $329.5K | — | — | — | 0.0% |
| Q1 2026 | 30.9K | $656.1K | $21.23 | $99.4K | $227.2K | 0.0% |